David Miyamoto, MD, PhD is Associate Professor of Radiation Oncology at Harvard Medical School, Co-Leader of the Harvard Cancer Consortium Prostate Cancer Program, and Associate Member of the Broad Institute of MIT and Harvard. His translational research laboratory in the Krantz Family Center for Cancer Research at Mass General Brigham Cancer Institute focuses on the development of novel biomarkers to guide bladder and prostate cancer therapy and improve the individualized care of each patient, with a particular emphasis on the molecular analysis of circulating tumor cells and tumor tissues using multi-omic approaches. Dr. Miyamoto is also a board-certified radiation oncologist specializing in genitourinary malignancies who sees patients at the Massachusetts General Hospital. At the national level he serves as Vice Chair of the NRG Oncology Translational Science Committee. His research efforts have been supported by grants from the National Cancer Institute, the U.S. Department of Defense, the Prostate Cancer Foundation, and the Radiation Oncology Institute.
Disclosures:
- Employment: Massachusetts General Hospital:Physician Investigator:Employee
- Compensation: Astellas Pharma, Inc.: Travel Expenses-End Date: 02/08/2026 ;National Institutes of Health: Research Grants, Research Funding, Research Salary Support, Grant Research Funding-End Date: To Present
- Ownership: none
- Leadership: Communications Medicine (Nature Portfolio):Editorial Board Member;Harvard Cancer Consortium:Co-Leader, Prostate Cancer Program;NRG Oncology:Vice Chair, Translational Science Committee